Found: 99
Select item for more details and to access through your institution.
Mitoxantrone: a new anticancer drug with significant clinical activity.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Risk factors for doxorubicin-induced congestive heart failure.
- Published in:
- 1979
- By:
- Publication type:
- journal article
VM 26 and VP 16-213: a comparative analysis.
- Published in:
- 1977
- By:
- Publication type:
- journal article
Nutritional parameters observed during 28-day infusion of recombinant human tumor necrosis factor-alpha.
- Published in:
- 1993
- By:
- Publication type:
- journal article
A method for the evaluation of dose-toxicity relationships in clinical trials.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Measure once or twice -- does it really matter?
- Published in:
- 1999
- By:
- Publication type:
- commentary
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Investigation of taxol as a potential radiation sensitizer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Hispanic patients with head and neck cancer do not have a worse prognosis than Anglo-American patients.
- Published in:
- 1992
- By:
- Publication type:
- journal article
A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Primary adrenal lymphoma.
- Published in:
- 1989
- By:
- Publication type:
- journal article
High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Determination of transforming growth factor activity in effusions from cancer patients.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Simultaneous in vitro drug sensitivity testing on tumors from different sites in the same patient.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assay.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Use of a human tumor cloning system to screen retinoids for antineoplastic activity.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Direct cloning of human breast cancer in soft agar culture.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Clonogenic assay and in vitro chemosensitivity testing of human urologic malignancies.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Ultrastructural analysis of colonies growing in a human tumor cloning system.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Growth of lung cancer colonies from bronchoscopy washings.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro.
- Published in:
- Prostate, 2000, v. 43, n. 3, p. 161, doi. 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O
- By:
- Publication type:
- Article
Perineural invasion and associated pain in pancreatic cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
- Published in:
- Scientific Reports, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41598-024-62470-9
- By:
- Publication type:
- Article
Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
- Published in:
- Oncogene, 2008, v. 27, p. S58, doi. 10.1038/onc.2009.354
- By:
- Publication type:
- Article
Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 581, p. 1, doi. 10.1126/scitranslmed.aaz3088
- By:
- Publication type:
- Article
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome.
- Published in:
- Dermatology Reports, 2011, v. 3, n. 3, p. 125, doi. 10.4081/dr.2011.e55
- By:
- Publication type:
- Article
Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183871
- By:
- Publication type:
- Article
Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165586
- By:
- Publication type:
- Article
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs.
- Published in:
- BMC Genomics, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2164-14-302
- By:
- Publication type:
- Article
Book Review.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
Analysis of the Role of Plasma 25‐Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e704, doi. 10.1002/onco.13645
- By:
- Publication type:
- Article
First‐in‐Human Phase I Study of MBC‐11, a Novel Bone‐Targeted Cytarabine‐Etidronate Conjugate in Patients with Cancer‐Induced Bone Disease.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 303, doi. 10.1634/theoncologist.2018-0707
- By:
- Publication type:
- Article
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 14, doi. 10.1634/theoncologist.2017-0665
- By:
- Publication type:
- Article
Prognostic Factors ofSurvival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 143, doi. 10.1634/theoncologist.2014-0394
- By:
- Publication type:
- Article
ONCOLOGY.
- Published in:
- 1983
- By:
- Publication type:
- Book Review
Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. “A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 6, p. 441, doi. 10.1177/1758834017699772
- By:
- Publication type:
- Article
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 10, p. 1247, doi. 10.1038/bjc.2017.67
- By:
- Publication type:
- Article
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Activity of daunomycin in solid tumors.
- Published in:
- 1976
- By:
- Publication type:
- research
<sup>18</sup>F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 2, p. 153, doi. 10.1038/bjc.2017.327
- By:
- Publication type:
- Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- corrected article